Sign in

    R. Dirk Allison

    Chief Executive Officer and Chairman of the Board at Addus Homecare Corp
    Board
    Since March 2021
    Age
    68 years
    Education
    Earned a Bachelor of Business Administration from the University of Louisiana at Monroe and a master's degree in business administration from the University of Dallas, and is a certified public accountant.
    Tenure
    Joined ADUS as a director in 2010, advanced to President and CEO in January 2016, and has served as Chief Executive Officer and Chairman of the Board since March 2021.

    Also at Addus Homecare Corp

    BP
    Brian Poff
    Executive Vice President and Chief Financial Officer
    CB
    Cliff Blessing
    Executive Vice President and Chief Development Officer
    DA
    Darby Anderson
    Executive Vice President and Chief Government Relations Officer

    About

    R. Dirk Allison is a seasoned executive recognized for his extensive leadership experience in the healthcare industry.

    He has demonstrated a robust career in strategic roles, most notably at ADUS where he began as a director in 2010 and advanced through key positions, ultimately serving as President and CEO before becoming the Chief Executive Officer and Chairman of the Board in March 2021.

    Beyond his tenure at ADUS, his career is marked by a history of executive roles in various healthcare companies, underscoring his expertise in business strategy, financial management, and operational effectiveness.

    $ADUS Performance Under R. Dirk Allison

    Past Roles

    OrganizationRoleDate RangeDetails
    National Mentor Holdings, Inc. Director April 2019 - January 2022 Holding company for Civitas Solutions, Inc.
    Sevita, Inc. Director April 2019 - January 2022 Position no longer active
    Addus HomeCare Corporation (ADUS) President and Chief Executive Officer January 2016 - March 2021 Held prior to becoming CEO and Chairman
    Addus HomeCare Corporation (ADUS) Director of the Company 2010 - March 2021 (inferred) Held before assuming current role as CEO and Chairman
    Curo Health Services, LLC Director 2013 - 2015 Hospice care provider
    Correctional Healthcare Companies, Inc. President and Chief Executive Officer 2013 - 2014 National provider of correctional healthcare solutions
    CCS Medical, Inc. President and Chief Executive Officer 2011 - 2013 Provider of mail-order diabetic supplies
    Odyssey Healthcare, Inc. (Nasdaq: ODSY) Senior Vice President, Chief Financial Officer, and Treasurer Joined in 2006 - N/A Provider of hospice services
    Omniflight, Inc. Executive Vice President and Chief Financial Officer N/A Operator of aviation support services to the healthcare industry
    Ardent Health Services LLC Executive Vice President and Chief Financial Officer Approximately 3.5 years Operator of acute care and behavioral care hospitals
    Renal Care Group, Inc. (NYSE: RCI) Executive Vice President, Chief Financial Officer, and Treasurer Approximately 4 years Operator of dialysis centers
    Various Healthcare Companies President and Chief Executive Officer 1987 - 1999 Led several publicly and privately held healthcare companies

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary $940,385 FY 2023Fixed base salary
    All Other Compensation $24,471 FY 2023Life Insurance Premium: $11,633 ; Personal Benefit: $11,638 ; Cell Phone Allowance: $1,200

    Performance Compensation

    Data from  FY 2023

    Restricted Stock Awards

    MetricValue
    Grant Date Feb 24, 2023
    Restricted Stock Awards (shares) 17,927 shares
    Grant Date Fair Value $1,874,985
    Performance Metric Adjusted EBITDA
    Threshold 50% payout at 90% of target
    Target 100% payout at 100% of target
    Maximum Payout 150% payout at 110% of target
    Vesting Schedule Vests over 3 years on Feb 24 of 2023, 2024, & 2025

    Non-Equity Incentive Plan Compensation

    MetricValue
    Grant Date Feb 24, 2023
    Compensation Amount$1,330,000
    Payment Date March 6, 2024
    Performance Metric Adjusted EBITDA
    Threshold 50% payout at 90% of target ($475,000)
    Target 100% payout at 100% of target ($950,000)
    Maximum Payout 150% payout at 110% of target ($1,425,000)
    Payment Terms Cash-based; no vesting